Gene transfer applied to the modulation of alloreactivity

Hematology and Cell Therapy

Volumn 38, Issue 2, 1996, Pages 221-224

  Tiberghien, P ^a,b   Cahn, J Y ^a,b   Contassot, E ^a,b   Ferrand, C ^a,b   Reynolds, C W ^a,b   Herve P ^b  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ALLOGENIC BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; GENE TRANSFER; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX VIRUS; HUMAN; T LYMPHOCYTE;

EID: 0030067643     PISSN: 14302772     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-996-0221-7     Document Type: Conference Paper

References (25)

1. Antin JH (1993) Graft-versus-leukemia: non longer an epiphenomenon. Blood 82 : 2273-2277
2. Beatty PG, Clift RA, Mickelson EM, et al (1985) Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313 : 765
3. Blaise D, Olive D, Michallet M, (1995) Impairment of leukaemia-free survival by addition of interleukin-2 receptor antibody to standard graft-versus-host prophylanas. Lancet 345 : 1144-1146
4. Bonini C, Verzeletti S, Servida P, et al (1994) Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo immuno-modulation after allo-BMT (abstract). Blood 84 [Suppl 1] : 110a
5. Borelli E, Heyman R, Hsi M, Evans RM (1988) Targeting of an inducible toxic phenotype in animal cells. Proc Natl Acad Sci USA 85 : 7572-7576
6. Bowden RA (1990) Infections in patients with graft-vs-host disease. In: Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K (eds) Graft-vs-host disease: immunology, pathophysiology, and treatment, Hematology, vol. 12. Dekker, New York, p 525
7. Burakoff SJ, Degg HJ, Ferrara J, Atkinson F (1990) Graft-versus-Host disease: immunology, pathophysiology and treatment. Hematology. Dekker, New York
8. Contassot E, Deschaseaux M, Certoux JM, et al (1994) Retroviral-mediated transfer of herpes-simplex thymidine kinase (HS-tk) gene in alloreactive T-lymphocytes (abstract). Blood 84 [Suppl 1] : 1403a
9. Elion GB, Furman PA, Fyfe JA, et al (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci USA 7 : 5716-5720
10. Furman PA, McGujirt PV, Keller PM, Fyfe JA, Elion GB (1980) Inhibition by acyclovir of cell growth and DNA synthesis of cell biochemically transformed with herpes virus genetic information. Virology 102 : 420-430
11. Herve P, Wijdenes J, Bergerat JP, et al (1990) Treatment of corticosteroid-resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10). Blood 75 : 1017
12. Heyman RA, Borrelli E, Lesley I, et al (1989) Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency. Proc Natl Acad Sci USA 86 : 2698-2702
13. Horrowitz MM, Gale RP, Sondel PM, et al (1990) Graft-vs-leukemia reactions after bone marrow transplantation. Blood 75 : 555
14. Kernan NA, Barsch G, Ash RC, et al (1993) Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. N Engl J Med 328 : 593
15. Kernan NA, Collins NH, Juliano L, et al (1990) Clonable T lymphocytes in T cell depleted bone marrow transplants correlate with the development of GvHD. Blood 75 : 776-780
16. Kit S, Leung WC, Jorgensen GN, Dubbs DR (1974) Distinctive properties of thymidine kinase isoymes induced by human and avian herpes virus. Int J Cancer 14 : 598-610
17. Kolb HJ, Mittermüller J, Clemm C, et al (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 12 : 2462
18. Marmont AM, Horowitz MM, Gale RP, et al (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood 78 : 2120
19. Nagler A, Ackerstein A, Or R, et al (1992) Adoptive immunotherapy with missmatched allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation (abstract). Exp Hematol 20 : 705
20. Racadot E, Cahn JY, Brion A, et al (1995) Immunological reconstitution after T-cell depleted BMT and infusion of a fixed low number of T-cells in 18 patients (abstract). Nouv Rev Fr Hematol 37 : 223a
21. Smith KO, Galloway KS, Kennell WL, et al (1982) A new nucleoside analog, 9{[2-hydroxy-1(hydroxymethyl) ethoxy] methyl} guanine, highly active in vitro against herpes simplex virus types 1 and 2. Antimicrob Agents Chemother 22 : 55-61
22. Storb R, Deeg HJ, Whitehead I, et al (1986) Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Engl J Med 314 : 729
23. Tiberghien P (1994) Use of suicide genes in gene therapy. J Leukocyte Biol 56 : 203-210
24. Tiberghien P, Delain M, Plouvier E, et al (1992) Allogeneic T-lymphocyte transfer ± IL-2 after autologous BMT for refractory hemopathies. 18th Annual Meeting of the European Bone Marrow Transplantation (EBMT) (abstract). Stockholm, Sweden, May 31-June 3
25. Tiberghien P, Reynolds CW, Keller J, et al (1994) Ganciclovir treatment of herpes simplex kinase-transduced primary T-lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84 : 1333-1341